Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab.
Publication
, Journal Article
Kirk, AD; Hale, DA; Swanson, SJ; Mannon, RB
Published in: Am J Transplant
May 2006
Duke Scholars
Published In
Am J Transplant
DOI
ISSN
1600-6135
Publication Date
May 2006
Volume
6
Issue
5 Pt 1
Start / End Page
1084 / 1085
Location
United States
Related Subject Headings
- Thyroiditis, Autoimmune
- Surgery
- Lymphocyte Depletion
- Kidney Transplantation
- Humans
- Female
- Antibodies, Neoplasm
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal
- Alemtuzumab
Citation
APA
Chicago
ICMJE
MLA
NLM
Kirk, A. D., Hale, D. A., Swanson, S. J., & Mannon, R. B. (2006). Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab. Am J Transplant, 6(5 Pt 1), 1084–1085. https://doi.org/10.1111/j.1600-6143.2006.01258.x
Kirk, A. D., D. A. Hale, S. J. Swanson, and R. B. Mannon. “Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab.” Am J Transplant 6, no. 5 Pt 1 (May 2006): 1084–85. https://doi.org/10.1111/j.1600-6143.2006.01258.x.
Kirk AD, Hale DA, Swanson SJ, Mannon RB. Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab. Am J Transplant. 2006 May;6(5 Pt 1):1084–5.
Kirk, A. D., et al. “Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab.” Am J Transplant, vol. 6, no. 5 Pt 1, May 2006, pp. 1084–85. Pubmed, doi:10.1111/j.1600-6143.2006.01258.x.
Kirk AD, Hale DA, Swanson SJ, Mannon RB. Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab. Am J Transplant. 2006 May;6(5 Pt 1):1084–1085.
Published In
Am J Transplant
DOI
ISSN
1600-6135
Publication Date
May 2006
Volume
6
Issue
5 Pt 1
Start / End Page
1084 / 1085
Location
United States
Related Subject Headings
- Thyroiditis, Autoimmune
- Surgery
- Lymphocyte Depletion
- Kidney Transplantation
- Humans
- Female
- Antibodies, Neoplasm
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal
- Alemtuzumab